Delivery Order SPE2DR25D1053-SPE2DR26FT531
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,963.74 on June 3, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and carries an ultimate completion date of June 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) at a firm fixed price of $1,846.89. This non-set-aside, competitively awarded contract represents a continuation of the company's extensive pharmaceutical supply relationship with DLA through its Medical Supply Chain. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Carvedilol ER 20 mg capsules (30-count) valued at $10,541.75. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) under a firm fixed price contract valued at $4,394.88. The award, issued on September 19, 2025, is scheduled for completion by September 22, 2025, and represents a non-set-aside, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $5,976.74. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Carvedilol ER 20 mg capsules in quantities of 30 units. This non-set-aside, competitively awarded contract carries a ceiling value of $1,436.98 with firm fixed pricing and is scheduled for completion by September 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,687.29. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) under a firm fixed-price contract valued at $1,279.74. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within the...
- On November 4, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $2,474.33 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count). This firm fixed-price, non-set-aside contract was awarded competitively and is scheduled for completion by November 5, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT531Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count package) under a firm fixed-price arrangement with a ceiling value of $2,257.23. This is a non-set-aside competitive award with an ultimate completion date of November 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a prime vendor for the DLA Medical Supply Chain, AmerisourceBergen serves critical pharmaceutical distribution needs for military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contracting portfolio demonstrates extensive capability in delivering brand-name and generic medications across multiple therapeutic domains through competitively awarded delivery orders with consistent firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/3/25 |